Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein

scientific article published on 25 January 2007

Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1053/J.GASTRO.2007.01.034
P8608Fatcat IDrelease_fviyxvji2fdprnglf4uwvdv3re
P698PubMed publication ID17408664

P2093author name stringJe-Ho Lee
In Young Park
Bo Hwa Sohn
Young-Hwa Chung
Dong Jin Suh
Eunsil Yu
Young Ik Lee
Stefan J Surzycki
P2860cites workDNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian developmentQ22010765
P433issue4
P407language of work or nameEnglishQ1860
P921main subjectHepatitis B virusQ6844
hepatitis BQ6853
P304page(s)1476-1494
P577publication date2007-01-25
P1433published inGastroenterologyQ4039279
P1476titleAberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein
P478volume132

Reverse relations

cites work (P2860)
Q42981671A zebrafish model of intrahepatic cholangiocarcinoma by dual expression of hepatitis B virus X and hepatitis C virus core protein in liver.
Q38239671Aberrant DNA methylation in hepatocellular carcinoma tumor suppression (Review).
Q34464701Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas
Q39045130An overview of epigenetics in Chinese medicine researches
Q45366085Analysis of DNA methylation in human BK virus
Q36216577Array-based profiling of the differential methylation status of CpG islands in hepatocellular carcinoma cell lines
Q59358229Cancer Progression Goes Viral: The Role of Oncoviruses in Aggressiveness of Malignancies
Q33988586Carboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma development
Q64110985Control of viral infections by epigenetic-targeted therapy
Q37371733Current progress in epigenetic research for hepatocarcinomagenesis
Q41970979DLEC1 Expression Is Modulated by Epigenetic Modifications in Hepatocelluar Carcinoma Cells: Role of HBx Genotypes
Q50042001DNA Tumor Virus Regulation of Host DNA Methylation and Its Implications for Immune Evasion and Oncogenesis
Q39711686DNA cytosine methylation in the bovine leukemia virus promoter is associated with latency in a lymphoma-derived B-cell line: potential involvement of direct inhibition of cAMP-responsive element (CRE)-binding protein/CRE modulator/activation transcr
Q111349214DNA hypermethylation level of ACTL6A may promote BmNPV infection in B. mori
Q33617129DNA methylation: potential biomarker in Hepatocellular Carcinoma.
Q36039537DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis
Q33579896DNA methyltransferases: a novel target for prevention and therapy
Q36993940Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis
Q41688315Diagnostic Value of the Methylation of Multiple Gene Promoters in Serum in Hepatitis B Virus-Related Hepatocellular Carcinoma.
Q88669421Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells
Q39688414Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1.
Q40090479Downregulated long non-coding RNA DREH promotes cell proliferation in hepatitis B virus-associated hepatocellular carcinoma
Q26827297Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer
Q37225429EVI1 promotes cell proliferation in HBx-induced hepatocarcinogenesis as a critical transcription factor regulating lncRNAs
Q60302168Effects of a single transient transfection of Ten-eleven translocation 1 catalytic domain on hepatocellular carcinoma
Q38667127Epigenetic Dysregulation in Virus-Associated Neoplasms
Q38692795Epigenetic Pathways of Oncogenic Viruses: Therapeutic Promises
Q36244215Epigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma
Q38286091Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma
Q35665775Epigenetic changes mediated by microRNA miR29 activate cyclooxygenase 2 and lambda-1 interferon production during viral infection
Q36415128Epigenetic control of metastasis-associated protein 1 gene expression by hepatitis B virus X protein during hepatocarcinogenesis.
Q36001887Epigenetic mechanisms in virus-induced tumorigenesis
Q90416073Epigenetic modulation in chronic hepatitis B virus infection
Q35666404Epigenetic modulation of insulin-like growth factor-II overexpression by hepatitis B virus X protein in hepatocellular carcinoma.
Q38446849Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer
Q35243806Epigenetic repression of E-cadherin expression by hepatitis B virus x antigen in liver cancer.
Q37781197Epigenetic reprogramming of host genes in viral and microbial pathogenesis
Q34619389Epigenetic signatures of alcohol abuse and hepatitis infection during human hepatocarcinogenesis.
Q30157007Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma
Q35793851Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
Q42234880Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway
Q26849263Epigenetics in liver disease
Q28079271Epigenetics in liver disease: from biology to therapeutics
Q39563462Expression of T-cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer
Q45378283Expression of pituitary tumor-transforming gene 1 (PTTG1)/securin in hepatitis B virus (HBV)-associated liver diseases: evidence for an HBV X protein-mediated inhibition of PTTG1 ubiquitination and degradation
Q28383729From hepatitis to hepatocellular carcinoma: a proposed model for cross-talk between inflammation and epigenetic mechanisms
Q38415638Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma
Q35084738Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.
Q38974653Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis
Q39372582Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
Q40722555Genome-wide identification of blood DNA methylation patterns associated with early-onset hepatocellular carcinoma development in hepatitis B carriers
Q58612842Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy
Q36689117Genomic responses to hepatitis B virus (HBV) infection in primary human hepatocytes.
Q90707727Global DNA 5-Hydroxymethylcytosine and 5-Formylcytosine Contents Are Decreased in the Early Stage of Hepatocellular Carcinoma
Q36401985Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study
Q36002022Global hypomethylation in hepatocellular carcinoma and its relationship to aflatoxin B(1) exposure.
Q34552627Glucocorticoid-induced S-adenosylmethionine enhances the interferon signaling pathway by restoring STAT1 protein methylation in hepatitis B virus-infected cells
Q41130200HBx genotype D represses GSTP1 expression and increases the oxidative level and apoptosis in HepG2 cells
Q46669089HBx-mediated miR-21 upregulation represses tumor-suppressor function of PDCD4 in hepatocellular carcinoma
Q36724900HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1/CDK2 signaling.
Q90284131Hepatitis B Virus X Protein Stimulates Virus Replication Via DNA Methylation of the C-1619 in Covalently Closed Circular DNA
Q38690987Hepatitis B Virus X and Regulation of Viral Gene Expression
Q26775635Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte
Q39119845Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha.
Q45353493Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin
Q37621008Hepatitis B virus X protein molecular functions and its role in virus life cycle and pathogenesis
Q39034561Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma
Q39682076Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis
Q40068189Hepatitis B virus X protein promotes the development of liver fibrosis and hepatoma through downregulation of miR-30e targeting P4HA2 mRNA.
Q45387956Hepatitis B virus X protein upregulates expression of SMYD3 and C-MYC in HepG2 cells
Q38110262Hepatitis B virus X protein-induced aberrant epigenetic modifications contributing to human hepatocellular carcinoma pathogenesis
Q37680071Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma
Q35606904Hepatitis B virus infection and the risk of hepatocellular carcinoma
Q39181943Hepatitis B virus inhibits liver regeneration via epigenetic regulation of urokinase-type plasminogen activator
Q45324907Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3.
Q33530611Hepatitis B virus replication induces methylation of both host and viral DNA.
Q27024874Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma
Q45389152Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription
Q38543225Hepatitis viruses exploitation of host DNA methyltransferases functions
Q37571496Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.
Q38156891How virus persistence can initiate the tumorigenesis process
Q54499445Hypomethylation of long interspersed nuclear element-1 in hepatocellular carcinomas.
Q37961724Hypomethylation of repeated DNA sequences in cancer.
Q45372624IL-32: A Host Proinflammatory Factor against Influenza Viral Replication Is Upregulated by Aberrant Epigenetic Modifications during Influenza A Virus Infection
Q92316251Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
Q28730441Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma
Q34732677Induction of cyclooxygenase-2 expression by hepatitis B virus depends on demethylation-associated recruitment of transcription factors to the promoter
Q34401887Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines
Q64290412Integrative analysis of h-prune as a potential therapeutic target for hepatocellular carcinoma
Q38837061Mechanism of Hepatitis B Virus Persistence in Hepatocytes and Its Carcinogenic Potential
Q38261140Metastatic tumor antigen in hepatocellular carcinoma: golden roads toward personalized medicine
Q28743228Methylation of the CpG sites only on the sense strand of the APC gene is specific for hepatocellular carcinoma
Q34284404MicroRNAs associated with HBV infection and HBV-related HCC.
Q93140597MicroRNA‑20 induces methylation of hepatitis B virus covalently closed circular DNA in human hepatoma cells
Q33855801Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma
Q26823512Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis
Q27686923Molecular mechanisms underlying occult hepatitis B virus infection
Q26745338Molecular pathogenesis of hepatocellular carcinoma and impact of therapeutic advances
Q98185008Multiple roles for hepatitis B and C viruses and the host in the development of hepatocellular carcinoma
Q37418293Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function.
Q37174094Overexpression of DNA methyltransferase 1 and its biological significance in primary hepatocellular carcinoma
Q38018996Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation
Q40281137Predictive model for inflammation grades of chronic hepatitis B: Large-scale analysis of clinical parameters and gene expressions.
Q35989817RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients
Q39437275Restitution of gene expression and histone acetylation signatures altered by hepatitis B virus through antiviral microRNA-like molecules in nontransformed murine hepatocytes.
Q35995683Serum IGFBP-3 is a more effective predictor than IGF-1 and IGF-2 for the development of hepatocellular carcinoma in patients with chronic HCV infection.
Q33968083Serum secreted frizzled-related protein 5 levels differentially decrease in patients with hepatitis B virus-associated chronic infection and hepatocellular carcinoma
Q26773251Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma
Q84032542Silencing of PCDH10 in hepatocellular carcinoma via de novo DNA methylation independent of HBV infection or HBX expression
Q49956187Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma
Q39924163Suppression of BRD4 inhibits human hepatocellular carcinoma by repressing MYC and enhancing BIM expression
Q26771469The Epigenetic Control of Hepatitis B Virus Modulates the Outcome of Infection
Q37142007The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer
Q64214332The emerging role of epigenetic modifiers in repair of DNA damage associated with chronic inflammatory diseases
Q39890460The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines
Q35081469The roles of hepatitis B virus-encoded X protein in virus replication and the pathogenesis of chronic liver disease
Q34561172The silence of MUC2 mRNA induced by promoter hypermethylation associated with HBV in Hepatocellular Carcinoma
Q37151661Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation
Q28389231Tumor suppressor and hepatocellular carcinoma
Q37681282Viral epigenomes in human tumorigenesis.
Q34617749Viral hepatocarcinogenesis
Q34135741Viral hit and run-oncogenesis: Genetic and epigenetic scenarios
Q38643087Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms
Q88595072[Chloroquine induces apoptosis of human hepatocellular carcinoma cells in vitro by miR-26b-mediated regulation of Mcl-1]
Q38986675miR-185 inhibits hepatocellular carcinoma growth by targeting the DNMT1/PTEN/Akt pathway
Q36230642microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma.

Search more.